Stockreport

Innate Pharma Reports Full Year 2025 Financial Results and Business Update [Yahoo! Finance]

Innate Pharma S.A. - American Depositary Shares  (IPHA) 
PDF financing options currently under negotiation, including pharma partnering and royalty structures IPH4502 (Nectin-4 ADC) shows preliminary anti-tumor activity with fav [Read more]